跳至主要内容
临床试验/NCT01801150
NCT01801150已完成4 期

Effect Of Nasal CPAP On Glycemic Control In Patients With Poorly Controlled Type 2 Diabetes And Sleep Apnea-Hypopnea Syndrome

Hospital Universitario La Paz2 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
61
试验地点
2
主要终点
Glycemic control

研究概览

简要总结

Aim: To assess if six months of treatment with CPAP associated with conventional drug therapy, contribute to improved glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome SAHS)

详细描述

Main objective:

To assess the effect of 6 months of CPAP treatment associated with conventional drug therapy on glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome (SAHS)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects 18 to 75 years old; diagnosis of type 2 diabetes mellitus; treatment with diet; oral antidiabetics or insulin stable in the last month; levels of HbA1c> 7.5% (if not supported clinic two controls to confirm with a difference not exceeding 0.5%); overweight or obese (BMI ≥ 25 kg/m2)

排除标准

  • professional drivers, risk profession or respiratory failure; excessive daytime sleepiness is very high (Epworth scale> 18); morbid obesity (BMI> 40 kg/m2); CPAP treatment

结局指标

主要结局

Glycemic control

时间窗: Six months

To assess the effect of 6 months of CPAP therapy and conventional treatment on glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome (SAHS)

次要结局

  • To determine additional effects of CPAP on insulin resistance in patients with type 2 diabetes and SAHS.(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco Garcia-Rio

PhD

Hospital Universitario La Paz

研究点 (2)

Loading locations...

相似试验